Table: Daito - 6-MTH group results

Daito Pharmaceutical

14/01/2026 06:32

Jan 14 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Nov 30, 2025        Nov 30, 2024     May 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             25.14               24.58            52.50    
                 (+2.3 pct)          (+2.0 pct)       (+3.7 pct)  
  Operating          1.63                1.47             3.00    
                 (+10.6 pct)         (-35.7 pct)      (+14.5 pct) 
  Recurring          1.76                1.47             3.00    
                 (+20.0 pct)         (-36.5 pct)      (+10.9 pct) 
  Net                1.23              908 mln            2.30    
                 (+35.8 pct)         (-41.5 pct)      (+20.5 pct) 
  EPS             41.32 yen           29.70 yen        76.70 yen  
  Ann Div                             70.00 yen        40.00 yen  
  -Q2 div         20.00 yen           35.00 yen                   
  -Q4 div                             35.00 yen        20.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T